Cargando…
Factors associated with wait times across the breast cancer treatment pathway in Ontario
BACKGROUND: Longer times from diagnosis to breast cancer treatment are associated with poorer prognosis. This study examined factors associated with wait times by phase in the breast cancer treatment pathway. METHODS: There were 1760 women eligible for the study, aged 50–69 diagnosed in Ontario with...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828452/ https://www.ncbi.nlm.nih.gov/pubmed/24255823 http://dx.doi.org/10.1186/2193-1801-2-388 |
_version_ | 1782291247955705856 |
---|---|
author | Plotogea, Amalia Chiarelli, Anna M Mirea, Lucia Prummel, Maegan V Chong, Nelson Shumak, Rene S O’Malley, Frances P Holloway, Claire M B |
author_facet | Plotogea, Amalia Chiarelli, Anna M Mirea, Lucia Prummel, Maegan V Chong, Nelson Shumak, Rene S O’Malley, Frances P Holloway, Claire M B |
author_sort | Plotogea, Amalia |
collection | PubMed |
description | BACKGROUND: Longer times from diagnosis to breast cancer treatment are associated with poorer prognosis. This study examined factors associated with wait times by phase in the breast cancer treatment pathway. METHODS: There were 1760 women eligible for the study, aged 50–69 diagnosed in Ontario with invasive breast cancer from 1995–2003. Multivariate logistic regression examined factors associated with greater than median wait times for each phase of the treatment pathway; from diagnosis to definitive surgery; from final surgery to radiotherapy without chemotherapy and from final surgery to chemotherapy. RESULTS: The median wait times were 17 days (Inter Quartile Range (IQR) = 0–31) from diagnosis to definitive surgery, 44 days (IQR = 34–56) from final surgery to postoperative chemotherapy and 75 days (IQR = 57–97) from final surgery to postoperative radiotherapy. Diagnosis during 2000–2003 compared to 1995–1999 was associated with significantly longer wait times for each phase of the treatment pathway. Higher income quintile was associated with longer wait time from diagnosis to surgery (OR = 1.47, 95% CI = 1.05-2.06) and shorter wait times from final surgery to radiotherapy (OR = 0.60, 95% CI = 0.37-0.96). Greater stage at diagnosis was associated with shorter wait times from diagnosis to definitive surgery (stage III vs I: OR = 0.49, 95% CI = 0.34-0.71). CONCLUSIONS: While diagnosis during the latter part of the study period was associated with significantly longer wait times for all phases of the treatment pathway, there were variations in the associations of stage and income quintile with wait times by treatment phase. Continued assessment of factors associated with wait times across the breast cancer treatment pathway is important, as they indicate areas to be targeted for quality improvement with the ultimate goal of improving prognosis. |
format | Online Article Text |
id | pubmed-3828452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-38284522013-11-19 Factors associated with wait times across the breast cancer treatment pathway in Ontario Plotogea, Amalia Chiarelli, Anna M Mirea, Lucia Prummel, Maegan V Chong, Nelson Shumak, Rene S O’Malley, Frances P Holloway, Claire M B Springerplus Research BACKGROUND: Longer times from diagnosis to breast cancer treatment are associated with poorer prognosis. This study examined factors associated with wait times by phase in the breast cancer treatment pathway. METHODS: There were 1760 women eligible for the study, aged 50–69 diagnosed in Ontario with invasive breast cancer from 1995–2003. Multivariate logistic regression examined factors associated with greater than median wait times for each phase of the treatment pathway; from diagnosis to definitive surgery; from final surgery to radiotherapy without chemotherapy and from final surgery to chemotherapy. RESULTS: The median wait times were 17 days (Inter Quartile Range (IQR) = 0–31) from diagnosis to definitive surgery, 44 days (IQR = 34–56) from final surgery to postoperative chemotherapy and 75 days (IQR = 57–97) from final surgery to postoperative radiotherapy. Diagnosis during 2000–2003 compared to 1995–1999 was associated with significantly longer wait times for each phase of the treatment pathway. Higher income quintile was associated with longer wait time from diagnosis to surgery (OR = 1.47, 95% CI = 1.05-2.06) and shorter wait times from final surgery to radiotherapy (OR = 0.60, 95% CI = 0.37-0.96). Greater stage at diagnosis was associated with shorter wait times from diagnosis to definitive surgery (stage III vs I: OR = 0.49, 95% CI = 0.34-0.71). CONCLUSIONS: While diagnosis during the latter part of the study period was associated with significantly longer wait times for all phases of the treatment pathway, there were variations in the associations of stage and income quintile with wait times by treatment phase. Continued assessment of factors associated with wait times across the breast cancer treatment pathway is important, as they indicate areas to be targeted for quality improvement with the ultimate goal of improving prognosis. Springer International Publishing 2013-08-19 /pmc/articles/PMC3828452/ /pubmed/24255823 http://dx.doi.org/10.1186/2193-1801-2-388 Text en © Plotogea et al.; licensee Springer. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Plotogea, Amalia Chiarelli, Anna M Mirea, Lucia Prummel, Maegan V Chong, Nelson Shumak, Rene S O’Malley, Frances P Holloway, Claire M B Factors associated with wait times across the breast cancer treatment pathway in Ontario |
title | Factors associated with wait times across the breast cancer treatment pathway in Ontario |
title_full | Factors associated with wait times across the breast cancer treatment pathway in Ontario |
title_fullStr | Factors associated with wait times across the breast cancer treatment pathway in Ontario |
title_full_unstemmed | Factors associated with wait times across the breast cancer treatment pathway in Ontario |
title_short | Factors associated with wait times across the breast cancer treatment pathway in Ontario |
title_sort | factors associated with wait times across the breast cancer treatment pathway in ontario |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828452/ https://www.ncbi.nlm.nih.gov/pubmed/24255823 http://dx.doi.org/10.1186/2193-1801-2-388 |
work_keys_str_mv | AT plotogeaamalia factorsassociatedwithwaittimesacrossthebreastcancertreatmentpathwayinontario AT chiarelliannam factorsassociatedwithwaittimesacrossthebreastcancertreatmentpathwayinontario AT mirealucia factorsassociatedwithwaittimesacrossthebreastcancertreatmentpathwayinontario AT prummelmaeganv factorsassociatedwithwaittimesacrossthebreastcancertreatmentpathwayinontario AT chongnelson factorsassociatedwithwaittimesacrossthebreastcancertreatmentpathwayinontario AT shumakrenes factorsassociatedwithwaittimesacrossthebreastcancertreatmentpathwayinontario AT omalleyfrancesp factorsassociatedwithwaittimesacrossthebreastcancertreatmentpathwayinontario AT hollowayclairemb factorsassociatedwithwaittimesacrossthebreastcancertreatmentpathwayinontario AT factorsassociatedwithwaittimesacrossthebreastcancertreatmentpathwayinontario |